Metabolic conditioning of CD8+ effector T cells for adoptive cell therapy
CD8 + effector T (T E ) cell proliferation and cytokine production depends on enhanced glucose metabolism. However, circulating T cells continuously adapt to glucose fluctuations caused by diet and inter-organ metabolite exchange. Here we show that transient glucose restriction (TGR) in activated CD...
Gespeichert in:
Veröffentlicht in: | Nature metabolism 2020-08, Vol.2 (8), p.703-716 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | CD8
+
effector T (T
E
) cell proliferation and cytokine production depends on enhanced glucose metabolism. However, circulating T cells continuously adapt to glucose fluctuations caused by diet and inter-organ metabolite exchange. Here we show that transient glucose restriction (TGR) in activated CD8
+
T
E
cells metabolically primes effector functions and enhances tumour clearance in mice. Tumour-specific TGR CD8
+
T
E
cells co-cultured with tumour spheroids in replete conditions display enhanced effector molecule expression, and adoptive transfer of these cells in a murine lymphoma model leads to greater numbers of immunologically functional circulating donor cells and complete tumour clearance. Mechanistically, T
E
cells treated with TGR undergo metabolic remodelling that, after glucose re-exposure, supports enhanced glucose uptake, increased carbon allocation to the pentose phosphate pathway (PPP) and a cellular redox shift towards a more reduced state—all indicators of a more anabolic programme to support their enhanced functionality. Thus, metabolic conditioning could be used to promote efficiency of T-cell products for adoptive cellular therapy.
Transient glucose restriction after the activation of CD8
+
T
E
cells ex vivo induces metabolic remodelling that enhances effector functions and tumour clearance in mice. |
---|---|
ISSN: | 2522-5812 2522-5812 |
DOI: | 10.1038/s42255-020-0256-z |